Biden Administration Launches $5B Program To Boost Development Of Pan-Coronavirus Vaccine, Treatments
- The White House plans to devote $5 billion to develop effective treatments and vaccines against current and future Covid variants, a Department of Health and Human Services (HHS) spokesperson and a Biden administration official said.
- The investment, "Project NextGen," first announced by White House and HHS officials in an interview with the Washington Post, is expected to be launched shortly as a sequel to the Trump Administration's 'Operation Warp Speed.'
- It will focus on creating long-lasting monoclonal antibodies resistant to new COVID-19 variants and broader vaccines that can protect against several coronaviruses.
- Also Read: Biden Signs COVID-19 Bill To Declassify Intelligence On Pandemic Origins.
- The project also seeks to speed up the development of vaccines that produce mucosal immunity and can be administered through the nose, hoping to reduce infection and transmission rates.
- The agency shifted funds intended for coronavirus testing and other priorities.
- 'It's been very clear to us that the market on this is moving very slowly,' Dr. Ashish Jhan, the White House's Covid response coordinator, told the Washington Post.
- 'There's a lot that government can do, the administration can do, to speed up those tools … for the American people,' he said.
- Photo by Johaehn from Pixabay
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Posted-In: Briefs COVID-19 CoronavirusBiotech Government News Health Care Financing General
